Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applied Gene and Cell Therapy Center (AGCTC) is a biotechnology company focused on the development and manufacturing of advanced therapy medicinal products (ATMPs). The company provides end-to-end solutions for gene and cell therapy development, ranging from early-stage research and process development to clinical-grade manufacturing. AGCTC specializes in viral vector production, including AAV and lentivirus, as well as non-viral delivery systems like mRNA and lipid nanoparticles. By integrating cutting-edge technology with regulatory expertise, the center aims to accelerate the transition of innovative therapies from the laboratory to the clinic for patients with rare diseases and cancer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied Gene and Cell Therapy Center.